 | Up a level |
Al-Kali, A.; Cortes, J.; Faderl, S.; Jones, D.; Abril, C.; Pierce, S.; Brandt, M.; Kantarjian, H.; Ravandi, F. (2011). Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemia. Clinical lymphoma, myeloma and leukemia, 11(4), pp. 361-6. Dallas, Tex.: CIG Media Group 10.1016/j.clml.2011.06.007
